Ryu Ogawa
- Molecular Biology
- Biomaterials top 10%
- Immunology and Allergy top 5%
- Radiology, Nuclear Medicine and Imaging
- Oncology
- Co-authors
- Seiichi TokuraHiroyuki SaimotoHitoshi SashiwaYoshihiro ShigemasaNorio NishiIchiro AzumaJunichi IidaI Saiki
- Topics
- Cell Adhesion Molecules Research (3 papers)Monoclonal and Polyclonal Antibodies Research (3 papers)Studies on Chitinases and Chitosanases (3 papers)
- Journals
- Carbohydrate PolymersIntensive Care MedicineInternational Journal of Biological Macromolecules
- Partner nations
- JapanUnited States
In The Last Decade
Ryu Ogawa
13 papers receiving 444 citations
Peers
Comparison fields: 5 of 81
- Molecular Biology 159
- Biomaterials 140
- Immunology and Allergy 114
- Radiology, Nuclear Medicine and Imaging 73
- Oncology 59
Countries citing papers authored by Ryu Ogawa
This map shows the geographic impact of Ryu Ogawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryu Ogawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryu Ogawa more than expected).
Fields of papers citing papers by Ryu Ogawa
This network shows the impact of papers produced by Ryu Ogawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryu Ogawa. The network helps show where Ryu Ogawa may publish in the future.
Co-authorship network of co-authors of Ryu Ogawa
This figure shows the co-authorship network connecting the top 25 collaborators of Ryu Ogawa. A scholar is included among the top collaborators of Ryu Ogawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryu Ogawa. Ryu Ogawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 24 | |
| 3 | [Distributive shock and it's therapy by cardio-vascular acting drugs]. | 2 |
| 4 | 54 | |
| 5 | 6 | |
| 6 | 16 | |
| 7 | 17 | |
| 8 | 3 | |
| 9 | 31 | |
| 10 | 38 | |
| 11 | 136 | |
| 12 | 10 | |
| 13 | Inhibition of the metastasis of murine malignant melanoma by synthetic polymeric peptides containing core sequences of cell-adhesive molecules. | 116 |
| 14 | 1 |
About Ryu Ogawa
Ryu Ogawa is a scholar working on Immunology and Allergy, Biotechnology and Biomaterials, having authored 14 papers that have together received 454 indexed citations. Recurring topics across this work include Cell Adhesion Molecules Research (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Studies on Chitinases and Chitosanases (3 papers). The work is most often cited by research in Immunology and Allergy (114 citations), Biomaterials (140 citations) and Pharmaceutical Science (48 citations). Ryu Ogawa has collaborated with scholars based in Japan and United States. Frequent co-authors include Seiichi Tokura, Hiroyuki Saimoto, Hitoshi Sashiwa, Yoshihiro Shigemasa, Norio Nishi, Ichiro Azuma, Junichi Iida, I Saiki, J Murata and Kazuyuki Sugimura. Their work appears in journals such as Carbohydrate Polymers, Intensive Care Medicine and International Journal of Biological Macromolecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.